LA Center for Bleeding and Clotting Disorders - Metairie — Metairie, Louisiana

LA Center for Bleeding and Clotting Disorders - Metairie is a clinical research site located in Metairie, Louisiana, United States 70001.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

LA Center for Bleeding and Clotting Disorders - Metairie has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Hemophilia B, Healthy Participants, Hemophilia A.

Sponsors: Pfizer, Equilibra Bioscience LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Metairie

Browse all research sites in Louisiana · View every site in Metairie

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for LA Center for Bleeding and Clotting Disorders - Metairie?

LA Center for Bleeding and Clotting Disorders - Metairie has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has LA Center for Bleeding and Clotting Disorders - Metairie conducted?

LA Center for Bleeding and Clotting Disorders - Metairie has 2 clinical trials on record, with 2 currently active. Their work covers Hemophilia B, Healthy Participants, Hemophilia A.

Is LA Center for Bleeding and Clotting Disorders - Metairie accredited by Crixeo Clinical Trials?

LA Center for Bleeding and Clotting Disorders - Metairie has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about LA Center for Bleeding and Clotting Disorders - Metairie?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.